Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 7:49 p.m.

    📋 Tarsus Pharmaceuticals Inc (TARS) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 08:41:17

    Event Type: Clinical Trial Update

    Event Details:

    Tarsus Pharmaceuticals Inc (TARS) Announces Clinical Trial Update Tarsus Pharmaceuticals Inc (TARS) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: XDEMVY, trial
    • Diseases/Conditions: Demodex blepharitis, XDEMVY
    • Clinical Stage: Phase 2 trial, Phase 2
    • Collaboration: XDEMVY
      • expected in 1H 2027

    🔬 Clinical Development Pipeline (Tarsus Pharmaceuticals Inc):

    Product Type Development Stage Therapeutic Area Source
    TP-03 DRUG Phase PHASE2 Meibomian Gland Dysfunction ClinicalTrials.gov
    PET/CT scan RADIATION Phase EARLY_PHASE1 Solid Tumor ClinicalTrials.gov
    89Zr-DFO-N-Suc-C9scFv BIOLOGICAL Phase EARLY_PHASE1 Solid Tumor ClinicalTrials.gov
    89Zr-DFO-N-Suc-F8scFv BIOLOGICAL Phase EARLY_PHASE1 Solid Tumor ClinicalTrials.gov
    TP-03 Vehicle DRUG Phase PHASE2 Meibomian Gland Dysfunction ClinicalTrials.gov
    Placebo DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    TP-05 (lotilaner oral capsules) DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    TP-05 (lotilaner oral), low-fat group DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    TP-05 (lotilaner oral), high-fat group DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    TP-05 (lotilaner oral), fasted group DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    TP-03, 0.25% DRUG Phase PHASE2 Blepharitis ClinicalTrials.gov
    Vehicle control gel OTHER Phase PHASE2 Papulopustular Rosacea ClinicalTrials.gov
    Lotilaner Gel, 2.0% DRUG Phase PHASE2 Papulopustular Rosacea ClinicalTrials.gov
    TP-03 (Lotilaner Ophthalmic Solution), 0.25% DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Vehicle of TP-03 DRUG Phase PHASE2 Meibomian Gland Dysfunction ClinicalTrials.gov
    Placebo Comparator DRUG Phase PHASE2 Healthy Volunteer ClinicalTrials.gov
    High Dose TP-05 DRUG Phase PHASE2 Healthy Volunteer ClinicalTrials.gov
    Low Dose TP-05 DRUG Phase PHASE2 Healthy Volunteer ClinicalTrials.gov
    Vehicle control DRUG Phase PHASE4 Demodex Blepharitis ClinicalTrials.gov
    Lotilaner ophthalmic solution, 0.25% DRUG Phase PHASE4 Demodex Blepharitis ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Tarsus Pharmaceuticals Inc
    • Ticker Symbol: TARS

Search

News categories